Artec 3D Launches Artec Studio Lite: Professional 3D Capture for Everyone November 18, 2025 Global 3D scanning leader Artec 3D has launched a new, accessible version of its software, Artec Studio Lite. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251118804372/en/ Designed to make Artec Studio’s professional 3D tools available to a larger audience, Artec Studio Lite pairs cutting-edge AI Photogrammetry with advanced 3D processing and analysis, [...]
Football Manager: Losses quadruple after game cancelled November 18, 2025 Losses quadrupled at Sports Interactive after its decision to cancel the release of Football Manager 25, it has been revealed. The London-headquartered video game maker has posted a pre-tax loss of £8.5m for the 12 months to 31 March, 2025, according to new accounts filed with Companies House. The latest total comes after the business [...]
ShipStation® Improves Fulfilment Efficiency for UK Businesses With Enhanced Platform Capabilities November 18, 2025 UK merchants can now seamlessly manage shipping operations with new inventory and analytics solutions, flexible plans including a free option, and product advancements
Ticket touts face UK crackdown after Oasis outrage November 18, 2025 UK ministers are set to outlaw the resale of tickets for live events at prices above their original face value, in a move aimed at tackling professional touts and secondary ticket platforms like Viagogo and StubHub. The crackdown, due to be announced this week, represents the most aggressive intervention yet in a market long criticised [...]
European Commission Grants Approval of Remsima™ IV Liquid Formulation, World’s First Liquid Formulation of IV Infliximab November 18, 2025 Remsima™ IV (intravenous) liquid formulation, the world’s first liquid formulation of IV infliximab has been approved by the European Commission (EC) for all previously approved indications for Remsima™ IV powder formulation1 The approval is based on the comparability data between infliximab powder formulation and the liquid formulation2 The new liquid formulation of infliximab, available in 100 mg and a newly introduced 350 mg presentation, eliminates the need for reconstitution and cuts drug preparation time by 51%, lowering preparation costs by 20% 1,3 Projected annual cost savings across seven European countries could reach up to €2.6 million, alongside significant improvements to workflow efficiency 3
Beyond by RS2 Becomes a Principal Issuing Member of Visa November 18, 2025 Beyond by RS2, the innovation brand of RS2 Financial Services GmbH, has become a Principal Issuing Member of Visa in Europe – allowing the company to directly issue Visa cards and to launch and manage payment card programs. With this milestone, Beyond by RS2 strengthens its position as an end-to-end payment partner, combining issuing, acquiring, [...]
Prime Ministers deserve a nicer house and we deserve better government November 18, 2025 The nerve centre of the British state, 10 Downing Street, is fantastically ill-suited to the needs of a modern Prime Minister and to the interests of the country. An excellent piece by Politico last week lifted the lid on what it’s actually like to work in this rather dilapidated Georgian townhouse, with one former No [...]
The British library is in crisis: why does nobody care? November 18, 2025 The widespread indifference to the British Library’s crippling cyberattack demonstrates a perilous failure to value the knowledge infrastructure vital for national prosperity, says Hetan Shah The head of a critical British information body has resigned. No, not the BBC. At the start of this month the chief executive of the British Library, the UK’s national [...]
‘Shenanigans’: Did the OBR save Reeves from hiking income taxes at the Budget? November 18, 2025 For weeks, Chancellor Rachel Reeves had been engaged in an extraordinary communications exercise of expectation management, leading Brits to believe that income tax was about to hiked for the first time in 50 years. In an unusual press conference earlier this month, she told journalists that everyone would have to contribute to the Labour government’s [...]
Celltrion Announces European Commission Approval of Additional Line Extension for Omlyclo™ 300mg November 18, 2025 Omlyclo™ (omalizumab) is the first and only omalizumab biosimilar approved in Europe Omlyclo™ 300 mg/2ml prefilled syringe (PFS) presentation is now approved in EU offering a simpler dosing schedule and improved patient adherence